Type 2 Diabetes With Nephropathy
1 clinical trials · Condition
◉ Watch Type 2 Diabetes With Nephropathy
| Record | Firm | Date |
|---|---|---|
| Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy (NCT00949351) | Lerdsin General Hospital | 2009-09-01 |
Track Type 2 Diabetes With Nephropathy automatically
Every clearance here is in the API, with alerts when new ones post.